31-10-002

Multicenter Open-label Study Investigating the Pharmacokinetics of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration to Patients with Schizophrenia

Study Information Study ID

31-10-002

Full Study Title

Multicenter Open-label Study Investigating the Pharmacokinetics of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration to Patients with Schizophrenia

Active Ingredient / Drug Information

Aripiprazole/Injectable suspension

Disease

Schizophrenia

Phase

CSR Summary

31-10-002 Clinical Summary.pdf